Gossamer Bio, Inc. Balance Sheet
GOSS / Health Care|9 years of annual SEC 10-K data (FY2017-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
Gossamer Bio, Inc. had $172M in total assets with negative shareholders' equity of $123M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37.7M | $46.1M | $32.1M | $112.0M | $183.4M | $486.1M | $135.0M | $105.2M | - |
| Accounts Receivable | $12.2M | $5.3M | $0 | - | - | - | - | - | - |
| Current Assets | $167.6M | $309.9M | $306.5M | $261.9M | $331.8M | $522.3M | $409.3M | $232.0M | - |
| PP&E (Net) | $64.0K | $10.0K | $1.6M | $4.0M | $5.3M | $5.5M | $5.4M | $3.2M | - |
| Total Assets | $172.2M | $315.3M | $311.9M | $272.4M | $343.7M | $539.4M | $426.6M | $239.4M | - |
| Current Liabilities | $63.4M | $45.0M | $51.6M | $49.2M | $39.9M | $38.6M | $36.9M | $20.4M | - |
| Total Debt | - | $0 | $814.0K | $12.0M | $29.1M | $28.7M | $28.5M | - | - |
| Shareholders' Equity | -$122.8M | $29.5M | $62.8M | $12.1M | $121.5M | $320.7M | $352.5M | -$120.1M | -$6.9M |